GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Cyclically Adjusted Revenue per Share

Hans Biomed (XKRX:042520) Cyclically Adjusted Revenue per Share : ₩6,030.72 (As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Hans Biomed's adjusted revenue per share for the three months ended in Mar. 2024 was ₩1,573.777. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩6,030.72 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Hans Biomed's average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Hans Biomed was 13.70% per year. The lowest was 12.10% per year. And the median was 12.90% per year.

As of today (2024-06-20), Hans Biomed's current stock price is ₩12260.00. Hans Biomed's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩6,030.72. Hans Biomed's Cyclically Adjusted PS Ratio of today is 2.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hans Biomed was 7.17. The lowest was 1.77. And the median was 2.79.


Hans Biomed Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Hans Biomed's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Cyclically Adjusted Revenue per Share Chart

Hans Biomed Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,518.37 4,151.47 4,610.12 5,177.53 5,850.84

Hans Biomed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,548.85 5,672.44 5,850.84 5,923.68 6,030.72

Competitive Comparison of Hans Biomed's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Hans Biomed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hans Biomed's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hans Biomed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hans Biomed's Cyclically Adjusted PS Ratio falls into.



Hans Biomed Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hans Biomed's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1573.777/118.8477*118.8477
=1,573.777

Current CPI (Mar. 2024) = 118.8477.

Hans Biomed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 640.453 99.353 766.120
201409 613.372 99.608 731.847
201412 601.818 99.098 721.757
201503 553.541 99.720 659.718
201506 671.328 100.050 797.459
201509 659.141 100.110 782.513
201512 673.867 100.220 799.117
201603 789.001 100.560 932.488
201606 795.498 100.790 938.021
201609 825.747 101.460 967.259
201612 1,020.197 101.560 1,193.857
201703 1,094.746 102.850 1,265.027
201706 1,249.155 102.610 1,446.830
201709 862.315 103.490 990.281
201712 1,120.039 102.990 1,292.495
201803 1,574.163 104.100 1,797.172
201806 1,997.573 104.130 2,279.909
201809 1,471.861 105.650 1,655.725
201812 1,605.619 104.350 1,828.693
201903 1,697.275 104.490 1,930.493
201906 1,733.878 104.880 1,964.792
201909 1,689.374 105.200 1,908.538
201912 1,797.892 105.120 2,032.680
202003 1,909.845 105.540 2,150.660
202006 1,964.893 104.870 2,226.786
202009 2,457.289 106.200 2,749.935
202012 1,830.925 105.765 2,057.395
202103 1,193.802 107.357 1,321.575
202106 1,548.813 107.579 1,711.055
202109 1,325.427 108.759 1,448.374
202112 1,756.901 109.676 1,903.816
202203 127.117 111.806 135.123
202206 2,050.997 114.083 2,136.661
202209 1,976.319 114.831 2,045.444
202212 2,089.870 115.200 2,156.040
202303 2,026.409 116.550 2,066.365
202306 1,702.645 117.140 1,727.468
202309 1,640.868 119.111 1,637.238
202312 1,576.723 118.848 1,576.723
202403 1,573.777 118.848 1,573.777

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Hans Biomed  (XKRX:042520) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hans Biomed's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12260.00/6030.72
=2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Hans Biomed was 7.17. The lowest was 1.77. And the median was 2.79.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Hans Biomed Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hans Biomed (XKRX:042520) Business Description

Traded in Other Exchanges
N/A
Address
8th Floor SK Building 16-4, Sungsu 1 ga Dong, Sungdong-gu, Seoul, KOR
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.

Hans Biomed (XKRX:042520) Headlines

No Headlines